The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Role of medical therapy in the management of uterine adenomyosis
Open accessAbstract
Adenomyosis is a benign uterine condition affecting women at various ages with different symptoms. The management of these patients is still controversial. Few clinical studies focusing on medical or surgical treatment for adenomyosis have been performed. No drug is currently labelled for adenomyosis and there are no specific guidelines to follow for the best management. Anyhow, medical treatments are effective in improving symptoms (pain, abnormal uterine bleeding and infertility). The rationale for using medical treatment is based on the pathogenetic mechanisms of adenomyosis: sex steroid hormones aberrations, impaired apoptosis, and increased inflammation. Several nonhormonal (i.e., nonsteroidal anti-inflammatory drugs) and hormonal treatments (i.e., progestins, oral contraceptives, gonadotropin-releasing hormone analogues) are currently used off-label to control pain symptoms and abnormal uterine bleeding in adenomyosis. Gonadotropin-releasing hormone analogues are indicated before fertility treatments to improve the chances of pregnancy in infertile women with adenomyosis. An antiproliferative and anti-inflammatory effect of progestins, such as dienogest, danazol and norethindrone acetate, suggests their use in medical management of adenomyosis mainly to control pain symptoms. On the other hand, the intrauterine device releasing levonorgestrel resulted is extremely effective in resolving abnormal uterine bleeding and reducing uterine volume in a long-term management plan. Based on new findings on pathogenetic mechanisms, new drugs are under development for the treatment of adenomyosis, such as selective progesterone receptor modulators, aromatase inhibitors, valproic acid, and anti-platelets therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The clinical treatment strategy for the two diseases also seems to be similar, and the drugs to treat the two diseases can be used interchangeably [11].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
den Bosch, T. V., Dueholm, M., Leone, F. P., Valentin, L., Rasmussen, C. K., Votino, A., Schoubroeck, D. V., Landolfo, C., Installé, A., Guerriero, S., et al. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14806 · Cited by 776
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
Marjoribanks, J., Ayeleke, R. O., Farquhar, C. M., & Proctor, M. L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001751.pub3 · Cited by 573
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
Taylor, H. S., Giudice, L. C., Lessey, B. A., Abrao, M. S., Kotarski, J., Archer, D. F., Diamond, M. P., Surrey, E., Johnson, N. P., Watts, N. B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700089 · Cited by 511
Naftalin, J., Hoo, W., Pateman, K., Mavrelos, D., Holland, T., & Jurkovic, D. (2012) · Human Reproduction · doi:10.1093/humrep/des332 · Cited by 337
Pathogenesis of adenomyosis, an update on molecular mechanisms
Vannuccini, S., Tosti, C., Carmona, F., Huang, S. J., Chapron, C., Guo, S.-W., & Petraglia, F. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.06.016 · Cited by 326
Self-citationChwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0001 · Cited by 310
Kitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Chapron, C., Tosti, C., Marcellin, L., Bourdon, M., Lafay-Pillet, M.-C., Millischer, A.-E., Streuli, I., Borghese, B., Petraglia, F., & Santulli, P. (2017) · Human Reproduction · doi:10.1093/humrep/dex088 · Cited by 294
Self-citationEffects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis
Younes, G., & Tulandi, T. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.025 · Cited by 272
Khan, K. N., Kitajima, M., Hiraki, K., Fujishita, A., Sekine, I., Ishimaru, T., & Masuzaki, H. (2009) · Human Reproduction · doi:10.1093/humrep/dep437 · Cited by 269
Flagged first, then by citations
2 of the 103 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Badawy, 2012, Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: A randomized controlled trial. Acta Obstet Gynecol, Scand, 91, 489
Cited by
Sorted by citations
Diagnosing adenomyosis: an integrated clinical and imaging approach
Chapron, C., Vannuccini, S., Santulli, P., Abrão, M. S., Carmona, F., Fraser, I. S., Gordts, S., Guo, S., Just, P., Noël, J., et al. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz049 · Cited by 439
Self-citationAdenomyosis: Mechanisms and Pathogenesis
Zhai, J., Vannuccini, S., Petraglia, F., & Giudice, L. C. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1716687 · Cited by 331
Self-citationRecent advances in understanding and managing adenomyosis
Vannuccini, S., & Petraglia, F. (2019) · F1000Research · doi:10.12688/f1000research.17242.1 · Cited by 298
Self-citationAdenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015
Yu, O., Schulze-Rath, R., Grafton, J., Hansen, K., Scholes, D., & Reed, S. D. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.01.016 · Cited by 200
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 199
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Guo, S.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020485 · Cited by 165
“be similar, and the drugs to treat the two diseases can be used interchangeably [11].”
BackgroundTellum, T., Nygaard, S., & Lieng, M. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.11.001 · Cited by 150
Harmsen, M. J., Wong, C. F. C., Mijatovic, V., Griffioen, A. W., Groenman, F. A., Hehenkamp, W. J. K., & Huirne, J. A. F. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz024 · Cited by 146
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
Inoue, S., Hirota, Y., Ueno, T., Fukui, Y., Yoshida, E., Hayashi, T., Kojima, S., Takeyama, R., Hashimoto, T., Kiyono, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13708-y · Cited by 143
Adenomyosis and Infertility—Review of Medical and Surgical Approaches
Szubert, M., Koziróg, E., Olszak, O., Krygier-Kurz, K., Kaźmierczak, J., & Wilczyński, J. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031235 · Cited by 99
Guideline No. 437: Diagnosis and Management of Adenomyosis
Dason, E. S., Maxim, M., Sanders, A. P., Smith, J. P., Ng, D., Chan, C., & Sobel, M. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.04.008 · Cited by 94
Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology
Guo, S. (2022) · Reproduction · doi:10.1530/rep-22-0224 · Cited by 93
Androgens, oestrogens and endometrium: a fine balance between perfection and pathology
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0106 · Cited by 76
Dessouky, R., Gamil, S. A., Nada, M. G., Mousa, R., & Libda, Y. I. (2019) · Insights into Imaging · doi:10.1186/s13244-019-0732-8 · Cited by 76
Donnez, J., Donnez, O., & Dolmans, M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.035 · Cited by 73
Moawad, G., Kheil, M. H., Ayoubi, J. M., Klebanoff, J. S., Rahman, S., & Sharara, F. I. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02476-2 · Cited by 71
Origin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far
Stratopoulou, C. A., Donnez, J., & Dolmans, M. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00361-w · Cited by 69
Conservative management of uterine adenomyosis: medical vs. surgical approach
Stratopoulou, C. A., Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214878 · Cited by 62
Gonadotropin-releasing hormone antagonist (linzagolix): A new therapy for uterine adenomyosis
Donnez, O., & Donnez, J. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.04.017 · Cited by 58
Endometriosis and adenomyosis: Similarities and differences
Donnez, J., Stratopoulou, C. A., & Dolmans, M.-M. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102432 · Cited by 57
Liu, L., Wang, T., & Lei, B. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1939443 · Cited by 54
Cozzolino, M., Cosentino, M., Loiudice, L., Martire, F. G., Galliano, D., Pellicer, A., & Exacoustós, C. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.11.034 · Cited by 55
Shen, X., Duan, H., Wang, S., Gan, L., Xu, Q., & Li, J.-J. (2019) · BioMed Research International · doi:10.1155/2019/5468954 · Cited by 53
Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists
Donnez, J., Stratopoulou, C. A., & Dolmans, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18199941 · Cited by 55
Current controversies in tubal disease, endometriosis, and pelvic adhesion
Goldberg, J. M., Falcone, T., & Diamond, M. P. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.06.021 · Cited by 53
Current and Prospective Treatment of Adenomyosis
Sharara, F. I., Kheil, M. H., Féki, A., Rahman, S., Klebanoff, J. S., Ayoubi, J. M., & Moawad, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153410 · Cited by 47
Hassanin, A. I., Youssef, A. A., Yousef, A. M., & Ali, M. K. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13600 · Cited by 46
Vercellini, P., Bandini, V., Viganò, P., Ambruoso, D., Cetera, G. E., & Somigliana, E. (2023) · Human Reproduction · doi:10.1093/humrep/dead206 · Cited by 45
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
Harada, T., Taniguchi, F., Guo, S., Choi, Y. M., Biberoglu, K. O., Tsai, S. S., Alborzi, S., Al‐Jefout, M., Chalermchockcharoenkit, A., Sison-Aguilar, A. G., et al. (2023) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12535 · Cited by 44
Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis
Matsushima, T., Akira, S., Fukami, T., Yoneyama, K., & Takeshita, T. (2018) · Gynecology and Minimally Invasive Therapy · doi:10.4103/gmit.gmit_35_18 · Cited by 43
Zhu, L., Chen, S., Che, X., Xu, P., Huang, X., & Zhang, X. (2019) · Journal of Pain Research · doi:10.2147/jpr.s205561 · Cited by 43
An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus
Kröncke, T. J. (2022) · British Journal of Radiology · doi:10.1259/bjr.20220121 · Cited by 43
Metabolomics for Diagnosis and Prognosis of Uterine Diseases? A Systematic Review
Tokarz, J., Adamski, J., & Rižner, T. L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040294 · Cited by 43
Vannuccini, S., Meleca, C. I., Toscano, F., Mertino, P., Pampaloni, F., Fambrini, M., Bruni, V., & Petraglia, F. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.103768 · Cited by 41
Self-citationAdenomyosis: An Update Concerning Diagnosis, Treatment, and Fertility
Selntigia, A., Molinaro, P., Tartaglia, S., Pellicer, A., Galliano, D., & Cozzolino, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175224 · Cited by 43
Adenomyosis and Adolescence: A Challenging Diagnosis and Complex Management
Martire, F. G., d’Abate, C., Schettini, G., Cimino, G., Ginetti, A., Colombi, I., Cannoni, A., Centini, G., Zupi, E., & Lazzeri, L. (2024) · Diagnostics · doi:10.3390/diagnostics14212344 · Cited by 38
Jiang, L., Han, Y., Song, Z., & Li, Y. (2023) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2023.03.015 · Cited by 35
Hai-yan, S., Lin, W., Shuhua, H., & Wang, W. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1679892 · Cited by 33
Zhu, L., Yang, X., Cao, B., Tang, S., & Tong, J. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.05.113 · Cited by 33
Matsushima, T., Akira, S., Yoneyama, K., & Takeshita, T. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1683818 · Cited by 32
Thirty years of mirena: A story of innovation and change in women’s healthcare
Gemzell‐Danielsson, K., Kubba, A., Caetano, C., Faustmann, T. A., Lukkari‐Lax, E., & Heikinheimo, O. (2021) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14110 · Cited by 32
Ota, I., Taniguchi, F., Ota, Y., Nagata, H., Wada, I., Nakaso, T., Ikebuchi, A., Sato, E., Azuma, Y., & Harada, T. (2021) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12408 · Cited by 34
The Impacts of Inflammatory and Autoimmune Conditions on the Endometrium and Reproductive Outcomes
Cuadrado-Torroglosa, I., García-Velasco, J. A., & Alecsandru, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133724 · Cited by 38
Adenomyosis: the missed disease
Santulli, P., Vannuccini, S., Bourdon, M., Chapron, C., & Petraglia, F. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104837 · Cited by 31
Self-citationRacilan, A. M., de Assis, W. A., Casalechi, M., Spagnuolo-Souza, A., Pascoal-Xavier, M. A., Silva, A. C. S. E., Puerto, H. L. D., & dos Reis, F. M. (2020) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/2284026520954068 · Cited by 30
Androgen Signaling in Uterine Diseases: New Insights and New Targets
Lv, M., Yu, J., Huang, Y., Ma, J., Xiang, J., Wang, Y., Li, L., Zhang, Z., & Liao, H. (2022) · Biomolecules · doi:10.3390/biom12111624 · Cited by 31
Radiofrequency Ablation for Adenomyosis
Dedes, I., Kolovos, G. N., Fruscalzo, A., Toub, D. B., Vaineau, C., Lanz, S., Imboden, S., Féki, A., & Mueller, M. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093069 · Cited by 30
Fertility preservation in women with benign gynaecological conditions
Santulli, P., Blockeel, C., Bourdon, M., Coticchio, G., Campbell, A., Vos, M. D., Macklon, K. T., Pinborg, A. B., & García-Velasco, J. A. (2023) · Human Reproduction Open · doi:10.1093/hropen/hoad012 · Cited by 30
The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review
Moawad, G., Youssef, Y., Fruscalzo, A., Faysal, H., Kheil, M. H., Pirtea, P., Guani, B., Ayoubi, J. M., & Féki, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196130 · Cited by 31
Pang, L.-L., JIN, M. L., Fan, L.-X., Zhao, T.-T., Li, R., & Wen, Y. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.688264 · Cited by 28
Chen, S., Wang, J., Sun, W., Zhu, L., He, J., & Zhang, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3420 · Cited by 27
Donnez, J., Donnez, O., Tourniaire, J., Brethous, M., Bestel, E., Garner, E. I. O., Charpentier, S., Humberstone, A., & Loumaye, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245794 · Cited by 28
Krentel, H., & Wilde, R. L. D. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103809 · Cited by 28
Health benefits of combined oral contraceptives – a narrative review
Bennink, H. J. T. C., van Gennip, F. A. M., Gerrits, M., Egberts, J. F. M., Gemzell‐Danielsson, K., & Kallner, H. K. (2024) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2024.2317295 · Cited by 33
Identifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis
Stratopoulou, C. A., Camboni, A., Donnez, J., & Dolmans, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194585 · Cited by 27
The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea
Che, X., Wang, J., He, J., Guo, X., Li, T., & Zhang, X. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.39252 · Cited by 27
Ji, M., Yuan, M., Jiao, X., Li, Q., Huang, Y., Li, J., & Wang, G. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2000961 · Cited by 25
Niu, X., Luo, Q., Wang, C., Zhu, L. J., & Huang, L. (2021) · Medicine · doi:10.1097/md.0000000000024597 · Cited by 24
Uterine Artery Embolization for Adenomyosis
Caridi, T. M. (2021) · Techniques in vascular and interventional radiology · doi:10.1016/j.tvir.2021.100726 · Cited by 24
Various types of adenomyosis and endometriosis: in search of optimal management
Guo, S. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.021 · Cited by 24
Modern view on the diagnostics and treatment of adenomyosis
Moldassarina, R. S. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-06982-1 · Cited by 26
The Effects of Anti-TGF-β1 on Epithelial–Mesenchymal Transition in the Pathogenesis of Adenomyosis
Kay, N., Huang, C., Shiu, L., Yu, Y.-C., Chang, Y., Suen, J., Tsai, E., & Huang, S.-T. J. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00139-0 · Cited by 26
Cozzolino, M., Pellicer, N., Galliano, D., & Pellicer, A. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.09.023 · Cited by 24
Wang, Y., Duan, H., Wang, S., Quan, Y., Huang, J., & Guo, Z. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00756-7 · Cited by 23
Peng, Y., Zhang, M., Yan, J., Wang, R., Yu, X., Zheng, X., Zhu, L., Fei, W., & Zhao, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01755b · Cited by 23
Clinical practice guidelines for endometriosis in Japan (The 3rd edition)
Harada, T., Taniguchi, F., Kitajima, M., Kitawaki, J., Koga, K., Momoeda, M., Mori, T., Murakami, T., Narahara, H., Osuga, Y., et al. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15416 · Cited by 25
Lv, N., Guo, J., Yuan, Q., Shen, S., Chen, Q., & Tong, J. (2023) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2023.10.012 · Cited by 20
Kolovos, G. N., Dedes, I., Imboden, S., & Mueller, M. D. (2024) · Healthcare · doi:10.3390/healthcare12161641 · Cited by 19
Nonsteroidal anti-inflammatory drugs for assisted reproductive technology
Nyachieo, A., Siristatidis, C. S., & Vaidakis, D. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007618.pub2 · Cited by 20
Hysteroscopy and female infertility: a fresh look to a busy corner
Stamenov, G., Vitale, S. G., Corte, L. D., Vilos, G. A., Parvanov, D. A., Nikolova, D. N., Ganeva, R., & Haimovich, S. (2020) · Human Fertility · doi:10.1080/14647273.2020.1851399 · Cited by 19
Ying, P., Li, H., Jiang, Y., Zhitao, Y., Lu, S., Yang, H., & Zhu, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9791498 · Cited by 18
The First Lugano Workshop on the role of adenomyosis in ART
Cozzolino, M., Bulun, S. E., de Ziegler, D., Exacoustós, C., Fatemi, H. M., García-Velasco, J. A., Horne, A. W., Petraglia, F., Santulli, P., Somigliana, E., et al. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104444 · Cited by 17
Self-citationZhang, H., Cao, B., Tong, J., Guo, J., Zheng, J., Zhu, L., Niu, Z., & Chen, L. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01932-6 · Cited by 18
Jin, T., Li, M., Li, T., Yan, S., Ran, Q., & Chen, W. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01189-w · Cited by 18
Peng, Y., Dai, Y., Yu, G., Yang, X., Wen, C., & Jin, P. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1967467 · Cited by 18
Barretta, M., Vignali, M., Marca, A. L., & Grandi, G. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2441981 · Cited by 18
Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development
Kobayashi, H. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01036-4 · Cited by 17
The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis
Guo, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030842 · Cited by 17
Biasioli, A., Degano, M., Restaino, S., Bagolin, M., Moro, F., Ciccarone, F., Testa, A. C., Greco, P., Scambia, G., Vizzielli, G., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12020463 · Cited by 17
Paolo, A. D., Vignini, A., Alia, S., Membrino, V., Carpini, G. D., Giannella, L., & Ciavattini, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113538 · Cited by 16
Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms
Che, X., Wang, J., Sun, W., He, J., Wang, Q., Zhu, D., Zhu, W., Zhang, J., Dong, J., Xu, J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17860 · Cited by 16
The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis
Ali, M. K., Hussein, R. S., Abdallah, K. S., & Mohamed, A. A. (2024) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2024.102795 · Cited by 15
A comparison of surgical outcomes between robot and laparoscopy-assisted adenomyomectomy
Shim, J. I., Jo, E.-H., Kim, M., Kim, M. K., Kim, M., Yun, B. S., Seong, S. J., & Jung, Y. W. (2019) · Medicine · doi:10.1097/md.0000000000015466 · Cited by 15
Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review
Rathinam, K. K., Abraham, J. J., Heema Preethy, S., Shevaani, S. A., Sen, M., George, M., & Ananthathandavan, P. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03256-0 · Cited by 14
Wu, Y., Yang, R., Lin, H., Lin, H., Cao, C., Jiao, X., & Zhang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.902083 · Cited by 14
Conservative surgical and drug therapies for adenomyosis Medicine
Fan, Y., Zhu, S., & Liang, X. (2022) · Reproductive Biology · doi:10.1016/j.repbio.2022.100664 · Cited by 14
Chan, I., Hsu, T., Shih, Y., Chang, Y., Wang, P., & Chen, Y. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14635 · Cited by 14
Adenomyosis and obstetric complications: A retrospective case–control study
de Rozario, T., Jochum, F., Schwaab, T., Garbin, O., Roy, C., & Host, A. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.11.011 · Cited by 14
Jin, Z., Liu, H., & Xu, C. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz194 · Cited by 14
Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix
Yamanaka, K., Washio, K., Uchida, A., Sasagawa, Y., Nishimoto, M., Yamasaki, Y., Nagamata, S., & Terai, Y. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2237121 · Cited by 13
Akhigbe, R. E., Afolabi, O. A., Adegbola, C. A., Akhigbe, T. M., Oyedokun, P. A., & Afolabi, O. A. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.07.038 · Cited by 13
Brun, J.-L., Plu‐Bureau, G., Huchon, C., Ah-Kit, X., Barral, M., Chauvet, P., Cornélis, F., Cortet, M., Crochet, P., Delporte, V., et al. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.07.001 · Cited by 13
Mitranovici, M.-I., Chiorean, D. M., Moraru, L., Moraru, R., Caravia, L. G., Tiron, A. T., Cotoi, T. C., Toru, H. S., & Cotoi, O. S. (2024) · Pharmaceuticals · doi:10.3390/ph17030311 · Cited by 12
Tellum, T., Qvigstad, E., Skovholt, E. K., & Lieng, M. (2019) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2019.02.002 · Cited by 12
Ono, Y., Ota, H., Takimoto, K., Tsuzuki, Y., Nakajima, A., Yoshino, O., Unno, N., Fujino, T., Fukushi, Y., & Wada, S. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102114 · Cited by 12
Zhang, K., Zhou, Z., Wang, C., Yu, M., Zhang, Y., Shi, Y., Wang, X., Liu, Y., Xu, L., Shi, W., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2624434 · Cited by 12
Zhu, H., Ma, Q., Dong, G., Yang, L., Li, Y., Song, S., & Mu, Y. (2022) · International Journal of Hyperthermia · doi:10.1080/02656736.2022.2161641 · Cited by 11
Exosomes: potential diagnostic markers and drug carriers for adenomyosis
Cheng, W.-X., Wei, S., Zhou, Y., Shao, Y., & Li, M.-Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1216149 · Cited by 11
Diagnosis and treatment of adenomyosis
Dason, E. S., Chan, C., & Sobel, M. L. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.201607 · Cited by 11
Adenomyosis: is an endocrine-related uterine dysfunction?
Vannuccini, S., & Petraglia, F. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2172156 · Cited by 11
Self-citation
Metadata
- Authors
- Vannuccini, S., Luisi, S., Tosti, C., Sorbi, F., & Petraglia, F.
- Affiliations
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Siena (IT)
- Corresponding author
- Petraglia, Felice
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 109
- Issue
- 3
- Pages
- 398-405
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2790094279
- Cited by
- 231
- References
- 103
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 33 · 2023: 37 · 2022: 40 · 2021: 38 · 2020: 20 · 2019: 17 · 2018: 2
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- adenomyosis, medical therapy, hormone therapy, GnRH analogues, progestins, dienogest, danazol, norethindrone acetate, levonorgestrel intrauterine device, nonsteroidal anti-inflammatory drugs, abnormal uterine bleeding, dysmenorrhea, infertility, sex hormones, apoptosis, inflammation, selective progesterone receptor modulators, aromatase inhibitors, valproic acid, antiplatelet therapy
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Female, Fertility Agents, Female, Humans, Intrauterine Devices, Medicated, Gonadotropin-Releasing Hormone, Progestins, Uterine Diseases, Drugs, Investigational, Treatment Outcome, Adenomyosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
